We’ve got a major breakthrough for you in Alzheimer’s disease research: For the first time ever, a team of scientists has identified which neurons are the first to be affected by the disease, potentially paving the way for therapies to build up neuronal resilience. This week, we also have research suggesting that recent depression diagnoses…
It may sound like something straight out of a sci-fi novel, but we assure you this week’s news of a newly developed nanoparticle drug-delivery system is quite real. The creators suggest the innovation could be three times more effective at crossing the blood-brain barrier than conventional systems. We also have details on the efficacy of…
We’re kicking off the new year with some great news about smells. While the overcast winter weather isn’t always much to look at, it can be a feast for the olfactory senses. The smells of fragrant burning logs and seasonal cooking waft right in. Along those lines, we’ve got some news about a treatment that…
Are you reading this on your cell phone? Well, if you’re prone to headaches, you may want to swing open the laptop instead. This week, we’re looking at the link between migraines and phone use, a potentially embarrassing and dangerous drug mix-up, neuroimaging disparities and—as always—so much more. Neuro Flashback Old MacDonald is beloved for…
Hold on to your hat, because this week we’re offering a whirlwind of new discoveries, exciting developments in biomarker research, and even a cry of “j’accuse!” directed at the FDA and a major pharmaceutical company. Neuro Flashback In its earliest days, neurology, like all medical specialties, was a little loose with its ethics. Here’s an…
